jnj-42847922
Showing 1 - 12 of 12
Renal Impairment Trial in Orlando, Knoxville (JNJ-42847922)
Completed
- Renal Impairment
- JNJ-42847922
-
Orlando, Florida
- +1 more
Jan 31, 2023
Healthy, Hepatic Impairment Trial in Kiel, Munchen (JNJ-42847922)
Completed
- Healthy
- Hepatic Impairment
- JNJ-42847922
-
Kiel, Germany
- +1 more
Mar 30, 2022
MDD Trial in Belgium, Germany, Netherlands (JNJ-42847922, Diphenhydramine, Placebo)
Completed
- Major Depressive Disorder
- JNJ-42847922
- +2 more
-
Aalst, Belgium
- +6 more
Feb 2, 2022
Insomnia Trial in Germany, Netherlands, United States (JNJ-42847922, Placebo)
Completed
- Insomnia
- JNJ-42847922
- Placebo
-
Hollywood, Florida
- +4 more
Jan 4, 2022
Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)
Completed
- Depressive Disorder, Major
- JNJ-42847922
- +5 more
-
Phoenix, Arizona
- +49 more
Jul 20, 2022
Healthy Trial in Antwerpen (Ethinyl Estradiol + Levonorgestrel, JNJ-42847922)
Completed
- Healthy
- Ethinyl Estradiol + Levonorgestrel
- JNJ-42847922
-
Antwerpen, BelgiumSGS Life Science Services
Dec 8, 2017
Healthy Trial in Leiden (JNJ-42847922, Zolpidem, Placebo)
Completed
- Healthy
- JNJ-42847922
- +2 more
-
Leiden, Netherlands(unnamed)
Mar 23, 2016
Healthy Trial in Overland Park (JNJ-42847922, Midazolam, Warfarin)
Completed
- Healthy
- JNJ-42847922
- +2 more
-
Overland Park, Kansas(unnamed)
Feb 19, 2016
Depressive Disorder, Major Trial in Berlin, Leiden (JNJ-42847922, Placebo)
Completed
- Depressive Disorder, Major
- JNJ-42847922
- Placebo
-
Berlin, Germany
- +1 more
Feb 3, 2016